C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion
- PMID: 15890767
- PMCID: PMC1769138
- DOI: 10.1136/hrt.2004.038661
C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion
Abstract
Background: To test the hypothesis that a high C reactive protein (CRP) concentration would predict recurrence of atrial fibrillation (AF) after cardioversion in patients taking antiarrhythmic drugs.
Methods: 111 patients who underwent direct current cardioversion for symptomatic AF were enrolled. Blood was drawn for CRP determination before cardioversion on the same day. All patients were taking antiarrhythmic drugs before and after electrical cardioversion.
Results: After a mean follow up of 76 days, 75 patients had recurrence of AF. In univariate analysis, the median CRP concentration was significantly higher in patients with AF recurrence (3.95 mg/l v 1.81 mg/l, p = 0.002). Among the 55 patients with CRP in the upper 50th centile, 44 (80%) experienced recurrence of AF over a total follow up of 8.98 patient years, whereas among the 56 patients with CRP in the lower 50th centile, 31 (55%) experienced recurrence of AF over a total follow up of 14.3 patient years (p < 0.001). The adjusted hazard ratio comparing the upper 50th centile of CRP with the lower 50th centile of CRP was 2.0 (95% confidence interval 1.2 to 3.2, p = 0.007).
Conclusions: CRP is independently associated with recurrence of AF after electrical cardioversion among patients taking antiarrhythmic drugs. These results suggest that inflammation may have a role in the pathogenesis of AF resistant to antiarrhythmic drugs.
Figures
Similar articles
-
Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.Am J Cardiol. 2007 May 15;99(10):1421-4. doi: 10.1016/j.amjcard.2006.12.074. Epub 2007 Apr 5. Am J Cardiol. 2007. PMID: 17493472
-
[Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion].Rev Esp Cardiol. 2006 Feb;59(2):125-9. Rev Esp Cardiol. 2006. PMID: 16540033 Spanish.
-
Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.Can J Cardiol. 2012 Sep-Oct;28(5):537-41. doi: 10.1016/j.cjca.2012.02.014. Epub 2012 May 1. Can J Cardiol. 2012. PMID: 22552174
-
Meta-analysis of association between C-reactive protein and immediate success of electrical cardioversion in persistent atrial fibrillation.Am J Cardiol. 2008 Jun 15;101(12):1749-52. doi: 10.1016/j.amjcard.2008.02.066. Epub 2008 Apr 16. Am J Cardiol. 2008. PMID: 18549852 Review.
-
[The contribution of inflammatory process in pathogenesis and natural history of atrial fibrillation].Pol Merkur Lekarski. 2005 Feb;18(104):227-8. Pol Merkur Lekarski. 2005. PMID: 17877137 Review. Polish.
Cited by
-
The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy.Int J Cardiovasc Imaging. 2014 Feb;30(2):431-8. doi: 10.1007/s10554-013-0339-y. Epub 2013 Nov 30. Int J Cardiovasc Imaging. 2014. PMID: 24293048 Review.
-
NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation.J Interv Card Electrophysiol. 2012 Jan;33(1):93-100. doi: 10.1007/s10840-011-9606-9. Epub 2011 Sep 21. J Interv Card Electrophysiol. 2012. PMID: 21938519
-
The efficacy of radiofrequency ablation in the treatment of pediatric arrhythmia and its effects on serum IL-6 and hs-CRP.Exp Ther Med. 2017 Oct;14(4):3563-3568. doi: 10.3892/etm.2017.4960. Epub 2017 Aug 18. Exp Ther Med. 2017. PMID: 29042948 Free PMC article.
-
Plasma profiles of matrix metalloproteinases and tissue inhibitors of the metalloproteinases predict recurrence of atrial fibrillation following cardioversion.J Cardiovasc Transl Res. 2013 Aug;6(4):528-35. doi: 10.1007/s12265-013-9471-2. Epub 2013 May 31. J Cardiovasc Transl Res. 2013. PMID: 23722357
-
Atrial Cardiomyopathy: Pathophysiology and Clinical Consequences.Cells. 2021 Sep 30;10(10):2605. doi: 10.3390/cells10102605. Cells. 2021. PMID: 34685585 Free PMC article. Review.
References
-
- Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825–33. - PubMed
-
- Waldo AL. Management of atrial fibrillation: the need for AFFIRMative action. AFFIRM investigators. Atrial fibrillation follow-up investigation of rhythm management. Am J Cardiol 1999;84:698–700. - PubMed
-
- Van Gelder IC, Tuinenburg AE, Schoonderwoerd BS, et al. Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation. Am J Cardiol 1999;84:147R–51R. - PubMed
-
- Van Gelder IC, Crijns HJ, Van Gilst WH, et al. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991;68:41–6. - PubMed
-
- Falk RH. Atrial fibrillation. N Engl J Med 2001;344:1067–78. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous